Welcome to our Media Center

Here in our Media Center we offer corporate press releases and other useful information for business media.


Curious about a pharma career? Come by and say hello #BIO2016 pic.twitter.com/10ZfKKPjR0
9 Jun
Exciting happenings at Bio 2016 tinyurl.com/zuu3756 #BIO2016
7 Jun
Verseon unveiling poster featuring new data for several promising oral anticoagulant drug candidates at ICHB, Paris. businesswire.com/news/home/2016…
12 Feb
Thank you @Caltech! We love talking to your students pic.twitter.com/2gHS1V6Ke4
20 Oct
Is Big Data a big part of drug discovery? Come by and ask us #HarvardBDT ocs.fas.harvard.edu/bdatfair
8 Oct
IMPORTANT NOTICE: None of the securities of Verseon have been registered under the US Securities Act and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

Proprietary Platform

Consistently designs novel drug candidates that are unlikely to be found using conventional methods


Drug Programs

Three different therapeutic areas, all with unmet (or poorly met) medical needs